About SynOx Therapeutics
synox therapeutics ltd was founded in november 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (tgct) and other indi... Read more
synox therapeutics ltd was founded in november 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (tgct) and other indi... Read more